Burlington Drug drops Namenda antitrust suit against Actavis
MLex Summary: Burlington Drug Company, a drug purchaser, has dropped a lawsuit accusing Actavis of trying to allocate the market for Namenda, an Alzheimer's drug. Burlington, which filed its lawsuit in...To view the full article, register now.
Already a subscriber? Click here to view full article